Search

Your search keyword '"Silverberg, Jonathan I"' showing total 282 results

Search Constraints

Start Over You searched for: Author "Silverberg, Jonathan I" Remove constraint Author: "Silverberg, Jonathan I" Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
282 results on '"Silverberg, Jonathan I"'

Search Results

2. Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials

4. Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial

8. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations

11. More than just methylisothiazolinone: Retrospective analysis of patients with isothiazolinone allergy in North America, 2017-2020

15. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials

16. Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials

24. Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms

30. Medical adhesive allergens: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2018

32. Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis

36. Bleach baths for atopic dermatitis: A systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADE

39. Age-related differences in patch testing results among children: Analysis of North American Contact Dermatitis Group Data, 2001-2018

44. Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial

46. Contact dermatitis to personal care products is increasing (but different!) in males and females: North American Contact Dermatitis Group data, 1996-2016

Catalog

Books, media, physical & digital resources